+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Cancer Diagnostics Market by Technology (Genetic Testing, Imaging, Molecular Diagnostics), Product (Consumables & Reagents, Equipment, Services), Indication, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Brain Cancer Diagnostics Market by Technology (Genetic Testing, Imaging, Molecular Diagnostics), Product (Consumables & Reagents, Equipment, Services), Indication, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Brain Cancer Diagnostics Market by Technology (Genetic Testing, Imaging, Molecular Diagnostics), Product (Consumables & Reagents, Equipment, Services), Indication, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011103
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The brain cancer diagnostics market is undergoing significant transformation, propelled by rapid advances in technology, growing clinical challenges, and the evolving demands of global healthcare systems. As new diagnostic tools emerge and regulatory environments shift, industry leaders must understand the changing landscape to drive effective decision-making, operational agility, and strategic investment.

Market Snapshot: Brain Cancer Diagnostics Market

The Brain Cancer Diagnostics Market grew from USD 4.52 billion in 2024 to USD 5.11 billion in 2025. It is expected to continue growing at a CAGR of 12.48%, reaching USD 9.15 billion by 2030.

Scope & Segmentation

This comprehensive report analyzes growth avenues and strategic opportunities in the brain cancer diagnostics sector across multiple segments and regions. Below is an overview of the covered areas:

  • Technology: Genetic Testing, Imaging (including CT Scan, MRI, PET), Molecular Diagnostics (NGS, PCR), and Pathology (Biopsy Analysis, Histopathology).
  • Product: Consumables & Reagents (Kits, Probes & Reagents), Equipment (Diagnostic Systems, Imaging Systems, Lab Instruments), Services (Maintenance, Training & Support).
  • Indication: Astrocytoma, Glioblastoma Multiforme, Meningioma, Oligodendroglioma.
  • Distribution Channel: Offline, Online.
  • End User: Diagnostic Laboratories, Hospitals, Research Institutes.
  • Region: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (notably United Kingdom, Germany, France, and other key territories), and Asia-Pacific (comprising China, India, Japan, Australia, and additional countries).
  • Companies Analyzed: General Electric Company, Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., QIAGEN N.V., Illumina, Inc., Abbott Laboratories, and Agilent Technologies, Inc.

Key Takeaways for Senior Decision-Makers

  • Technological integration is reshaping diagnostic workflows, with innovations like next-generation sequencing and advanced imaging enabling more accurate tumor characterization and detection.
  • Collaboration among academic centers, clinical sites, and industry partners accelerates translation of research advances to clinical adoption, reducing time-to-market for novel diagnostics.
  • Regulatory adaptation remains essential as evolving frameworks impact approval timelines, enable adaptive clinical trials, and support the use of real-world evidence for faster market access.
  • Personalization of brain cancer diagnostics is advancing, allowing clinicians to tailor therapies based on molecular profiling and comprehensive tumor analysis, improving patient outcomes.
  • Cloud-based analytics and software-as-a-service offerings are emerging to facilitate efficient data management, remote consultation, and seamless predictive modeling across healthcare networks.

Examining Tariff Impact on Supply Chain and Technology Adoption

Recent tariffs implemented in the United States are altering procurement decisions within the brain cancer diagnostics industry. These measures have prompted manufacturers to explore localized production and new supplier partnerships to mitigate rising costs for imaging systems and molecular assays. For senior leaders, this dynamic underscores the need for resilient supply chains, adaptable sourcing strategies, and ongoing regulatory advocacy to support uninterrupted access to critical diagnostic tools.

Methodology & Data Sources

This analysis combines primary interviews with clinical experts, laboratory directors, and industry executives, along with systematic reviews of regulatory filings, trial registries, white papers, peer-reviewed journals, and patent databases. Data consistency and accuracy were reinforced through triangulation and validation by a panel of sector thought leaders.

Why This Report Matters

  • Enables informed strategic planning by providing clarity on market direction, technology evolution, and regional nuances.
  • Supports risk mitigation through detailed supply chain and policy analysis, highlighting actionable tactics for operational resilience.
  • Guides investment priorities by uncovering emerging trends and revealing best-in-class approaches to diagnostic workforce optimization and clinical adoption.

Conclusion

Strategic leadership in brain cancer diagnostics depends on agility, innovation, and collaborative execution. This report equips stakeholders with actionable intelligence to navigate complexity, capitalize on new growth opportunities, and advance precision diagnostics across global healthcare markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of next generation sequencing for personalized brain tumor molecular profiling
5.2. Integration of artificial intelligence algorithms in MRI analysis to improve diagnostic accuracy
5.3. Development of liquid biopsy assays for noninvasive detection of glioblastoma recurrence and progression
5.4. Emergence of multiplex immunoassay panels for simultaneous detection of neural protein biomarkers
5.5. Expansion of telemedicine platforms for remote neuroimaging review and multidisciplinary consultation
5.6. Advancements in PET tracers targeting tumor metabolism for earlier brain cancer detection and monitoring
5.7. Regulatory approvals driving commercialization of point-of-care glioma diagnostic devices in clinical settings
5.8. Growth of integrated diagnostic platforms combining imaging, genomics, and proteomics data for precision medicine
5.9. Increasing collaboration between pharmaceutical and diagnostic firms to co-develop companion brain cancer tests
5.10. Rising demand for cost-effective screening solutions in emerging markets to improve brain tumor early detection rates
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Brain Cancer Diagnostics Market, by Technology
8.1. Introduction
8.2. Genetic Testing
8.3. Imaging
8.3.1. CT Scan
8.3.2. MRI
8.3.3. PET
8.4. Molecular Diagnostics
8.4.1. NGS
8.4.2. PCR
8.5. Pathology
8.5.1. Biopsy Analysis
8.5.2. Histopathology
9. Brain Cancer Diagnostics Market, by Product
9.1. Introduction
9.2. Consumables & Reagents
9.2.1. Kits
9.2.2. Probes & Reagents
9.3. Equipment
9.3.1. Diagnostic Systems
9.3.2. Imaging Systems
9.3.3. Lab Instruments
9.4. Services
9.4.1. Maintenance
9.4.2. Training & Support
10. Brain Cancer Diagnostics Market, by Indication
10.1. Introduction
10.2. Astrocytoma
10.3. Glioblastoma Multiforme
10.4. Meningioma
10.5. Oligodendroglioma
11. Brain Cancer Diagnostics Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Brain Cancer Diagnostics Market, by End User
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Hospitals
12.4. Research Institutes
13. Americas Brain Cancer Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Brain Cancer Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Brain Cancer Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. General Electric Company
16.3.2. Siemens Healthineers AG
16.3.3. Koninklijke Philips N.V.
16.3.4. Canon Medical Systems Corporation
16.3.5. F. Hoffmann-La Roche Ltd.
16.3.6. Thermo Fisher Scientific Inc.
16.3.7. QIAGEN N.V.
16.3.8. Illumina, Inc.
16.3.9. Abbott Laboratories
16.3.10. Agilent Technologies, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BRAIN CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BRAIN CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BRAIN CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BRAIN CANCER DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. BRAIN CANCER DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. BRAIN CANCER DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. BRAIN CANCER DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRAIN CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CT SCAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CT SCAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY NGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY NGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PROBES & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PROBES & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY LAB INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY LAB INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TRAINING & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TRAINING & SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ASTROCYTOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ASTROCYTOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GLIOBLASTOMA MULTIFORME, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY GLIOBLASTOMA MULTIFORME, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MENINGIOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY OLIGODENDROGLIOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY OLIGODENDROGLIOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 142. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 143. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 144. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 145. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 146. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 147. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 148. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 149. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 150. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 151. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 152. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 153. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 154. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 155. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 164. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 165. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 166. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 167. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 170. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 171. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 174. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 175. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 176. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 177. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 276. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 277. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 278. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 279. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 280. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 281. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 282. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 283. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 284. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 285. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 286. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 287. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 288. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 289. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 298. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 299. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 300. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 301. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 302. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 303. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 304. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 305. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2024 (USD MILLION)
TABLE 306. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2025-2030 (USD MILLION)
TABLE 307. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 308. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 309. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 310. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 311. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA BRAIN CANCER DIAGNOSTICS MARKET S

Samples

Loading
LOADING...

Companies Mentioned

  • General Electric Company
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Illumina, Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.11 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.15 Billion
Compound Annual Growth Rate12.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Brain Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Brain Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Artificial Intelligence In Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Artificial Intelligence In Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
AI in Cancer Diagnostics Market Report 2025 - Product Image

AI in Cancer Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Artificial Intelligence in Cancer Diagnostics Market Report 2025 - Product Image

Artificial Intelligence in Cancer Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
AI In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Cancer Type, By End-use (Hospitals, Surgical Centers and Medical Institutes), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

AI In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Cancer Type, By End-use (Hospitals, Surgical Centers and Medical Institutes), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From

About the Brain Cancer Diagnostics Market

In the realm of medical diagnostics, the Brain Cancer Diagnostics market is a specialized segment focused on the identification and characterization of brain tumors. Diagnostics for brain cancer are critical for formulating effective treatment plans, as the nature and progression of brain tumors can vary greatly. The market includes various diagnostic modalities such as imaging techniques, biopsy procedures, and molecular and genetic tests. Imaging tests such as MRI and CT scans are often the first step in diagnosing brain cancer, providing detailed images of the brain to detect abnormalities. Biopsies, wherein tissue samples are extracted from the suspected cancerous region, provide definitive diagnosis. Advanced methods to analyze tissue samples include histopathological examination, immunohistochemistry, and molecular testing, which can give insight into specific genetic mutations and markers that may influence treatment strategies. As medical technology advances, the introduction of new diagnostic tools and methods continues to evolve the field. With the integration of artificial intelligence and machine learning, there is a growing potential for improved diagnosis accuracy and personalized treatment approaches. Some notable companies operating in the Brain Cancer Diagnostics market include GE Healthcare, Philips Healthcare, Siemens Healthineers, Hitachi Medical Corporation, and Agilent Technologies. These organizations are involved in the production of imaging equipment, development of molecular diagnostics, and provision of services essential for the accurate diagnosis and management of brain cancers. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.